Cargando…

Experimental Validation of Novel Glypican 3 Exosomes for the Detection of Hepatocellular Carcinoma in Liver Cirrhosis [Corrigendum]

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2022
Materias:	Corrigendum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9439072/ https://www.ncbi.nlm.nih.gov/pubmed/36061236 http://dx.doi.org/10.2147/JHC.S386422

Ejemplares similares

Experimental Validation of Novel Glypican 3 Exosomes for the Detection of Hepatocellular Carcinoma in Liver Cirrhosis
por: Aydin, Yucel, et al.
Publicado: (2021)

Corrigendum to “Prebiotics: A Novel Approach to Treat Hepatocellular Carcinoma”
por: Fatima, Naz, et al.
Publicado: (2017)

Egyptian Society of Liver Cancer Recommendation Guidelines for the Management of Hepatocellular Carcinoma [Corrigendum]
Publicado: (2023)

Impaired Autophagy Response in Hepatocellular Carcinomas Enriches Glypican-3 in Exosomes, Not in the Microvesicles
por: Koksal, Ali Riza, et al.
Publicado: (2022)

Glypican-3, Vascular Endothelial Growth Factor and Golgi Protein-73 for Differentiation between Liver Cirrhosis and Hepatocellular Carcinoma
por: Mamdouh, Samah, et al.
Publicado: (2023)

The role of exosomes in hepatitis, liver cirrhosis and hepatocellular carcinoma
por: Shen, Jiliang, et al.
Publicado: (2017)

Diagnostic Value of Glypican-3 for Hepatocellular Carcinomas
por: El-Saadany, Sherif, et al.
Publicado: (2018)

Glypican 3-Targeted Therapy in Hepatocellular Carcinoma
por: Nishida, Takahiro, et al.
Publicado: (2019)

Drug-Related Hypertension Associated with the Efficacy of Apatinib on Hepatocellular Carcinoma [Corrigendum]
Publicado: (2020)

Corrigendum to “The Oncogenic Role of ARG1 in Progression and Metastasis of Hepatocellular Carcinoma”
por: You, Jia, et al.
Publicado: (2019)

Corrigendum to: Downregulation of SETD5 Suppresses the Tumorigenicity of Hepatocellular Carcinoma Cells
por: Park, Mijin, et al.
Publicado: (2022)

miR-500a-3p is a Potential Prognostic Biomarker in Hepatocellular Carcinoma [Corrigendum]
Publicado: (2022)

Glypican-3: A molecular marker for the detection and treatment of hepatocellular carcinoma(☆)
por: Shih, Tsung-Chieh, et al.
Publicado: (2020)

Glypican-3: A Novel and Promising Target for the Treatment of Hepatocellular Carcinoma
por: Zheng, Xiufeng, et al.
Publicado: (2022)

Corrigendum to “Cell Cycle Genes Are Potential Diagnostic and Prognostic Biomarkers in Hepatocellular Carcinoma”
por: Liping, Xu, et al.
Publicado: (2020)

Clinical Significance of the HHLA2 Protein in Hepatocellular Carcinoma and the Tumor Microenvironment [Corrigendum]
Publicado: (2021)

S-nitroso-N-acetylcysteine attenuates liver fibrosis in experimental nonalcoholic steatohepatitis [Corrigendum]
Publicado: (2013)

Corrigendum: Bridging and downstaging role of trans-arterial radio-embolization for expected small remnant volume before liver resection for hepatocellular carcinoma
por: Shehta, Ahmed, et al.
Publicado: (2021)

Circulating Serum Exosomal aHIF Is A Novel Prognostic Predictor For Epithelial Ovarian Cancer [Corrigendum]
Publicado: (2019)

Corrigendum to Long Noncoding RNA PTTG3P Expression Is an Unfavorable Prognostic Marker for Patients With Hepatocellular Carcinoma
Publicado: (2020)

Oridonin Sensitizes Hepatocellular Carcinoma to the Anticancer Effect of Sorafenib by Targeting the Akt Pathway [Corrigendum]
Publicado: (2021)

IL-6/STAT3 Signaling Contributes to Sorafenib Resistance in Hepatocellular Carcinoma Through Targeting Cancer Stem Cells [Corrigendum]
Publicado: (2020)

Corrigendum to “Synergistic Effect of MiR-146a Mimic and Cetuximab on Hepatocellular Carcinoma Cells”
por: Huang, Suning, et al.
Publicado: (2020)

Machine Learning to Improve Prognosis Prediction of Early Hepatocellular Carcinoma After Surgical Resection [Corrigendum]
Publicado: (2021)

Downregulation of CENPK Suppresses Hepatocellular Carcinoma Malignant Progression through Regulating YAP1 [Corrigendum]
Publicado: (2022)

Suppressing Growth and Invasion of Human Hepatocellular Carcinoma Cells by Celecoxib Through Inhibition of Cyclooxygenase-2 [Corrigendum]
Publicado: (2021)

Corrigendum to “System Analysis of ROS-Related Genes in the Prognosis, Immune Infiltration, and Drug Sensitivity in Hepatocellular Carcinoma”
por: Xu, Jun Hui, et al.
Publicado: (2022)

Corrigendum to: Regorafenib reverses HGF‐induced sorafenib resistance by inhibiting epithelial‐mesenchymal transition in hepatocellular carcinoma
Publicado: (2022)

Evaluating clinical and prognostic implications of Glypican-3 in hepatocellular carcinoma
por: Kaseb, Ahmed Omar, et al.
Publicado: (2016)

Glypican-3-Targeted Alpha Particle Therapy for Hepatocellular Carcinoma
por: Bell, Meghan M., et al.
Publicado: (2020)

Corrigendum to “Peritumoral EpCAM Is an Independent Prognostic Marker after Curative Resection of HBV-Related Hepatocellular Carcinoma”
por: Dai, Xiao-Meng, et al.
Publicado: (2017)

Glucosamine-6-Phosphate Isomerase 1 Promotes Tumor Progression and Indicates Poor Prognosis in Hepatocellular Carcinoma [Corrigendum]
Publicado: (2020)

Corrigendum to “EF24 Suppresses Invasion and Migration of Hepatocellular Carcinoma Cells In Vitro via Inhibiting the Phosphorylation of Src”
por: Zhao, Ran, et al.
Publicado: (2021)

Corrigendum to Hypoxia‐induced cofilin 1 promotes hepatocellular carcinoma progression by regulating the PLD1/AKT pathway
Publicado: (2022)

[Corrigendum] MicroRNA‑92a contributes to tumor growth of human hepatocellular carcinoma by targeting FBXW7
por: Yang, Wei, et al.
Publicado: (2023)

Corrigendum to “Validation of a Highly Sensitive qPCR Assay for the Detection of Plasma Cell-Free Epstein-Barr Virus DNA in Nasopharyngeal Carcinoma Diagnosis”
Publicado: (2020)

Alpha-Fetoprotein, Protein Induced by Vitamin K Absence or Antagonist II and Glypican-3 for the Detection and Prediction of Hepatocellular Carcinoma in Patients with Cirrhosis of Viral Etiology
por: Caviglia, Gian Paolo, et al.
Publicado: (2020)

Corrigendum to “The Chinese Medicine, Jiedu Recipe, Inhibits the Epithelial Mesenchymal Transition of Hepatocellular Carcinoma via the Regulation of Smad2/3 Dependent and Independent Pathways”
por: Liang, Shufang, et al.
Publicado: (2022)

Corrigendum to ‘Level of MFAP4 in ascites independently predicts 1-year transplant-free survival in patients with cirrhosis’ [JHEP Reports 3 (2021) 100287]
por: Torp, Nikolaj, et al.
Publicado: (2021)

Corrigendum to “Urinary Exosomal MicroRNA Profiling in Incipient Type 2 Diabetic Kidney Disease”
por: Xie, Yijun, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_oe0jqilvu3t2hkcvgbrcg0kmkk